Cerca
Menu
Foto del docente

Marco Rinaldo Oggioni

Full Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/19 Microbiology

Publications

vai alle Pubblicazioni

Publications prior to 2004

  1. Farzand R, K Rajakumar, MR Barer, PPE Freestone,GV Mukamolova,MR Oggioni,HM O’Hare. A virulence associated siderophore importer causes antimicrobial efflux in Klebsiella pneumoniae. bioRxiv 2020 October 8; doi: 10.1101/2020.10.07.329581
  2. Huang X, J Wang, J Li, Y Liu, X Liu, Z Li, K Kurniyati, Y Deng, G Wang, J Ralph, M De Ste Croix,S Escobar-Gonzalez, R Roberts, J-W Veening, X Lan, MR Oggioni*, C Li*, J-R Zhang*. Prevalence of Phase Variable Epigenetic Invertons among Host-Associated Bacteria. Nucleic Acid Research 2020 Oct 29:gkaa907. doi: 10.1093/nar/gkaa907.
  3. Zbinden FR, M De Ste Croix, D Grandgirard, RD Haigh, I Vacca, R Zamudio, ECA Goodall, R Stephan, MR Oggioni, SL Leib. Pathogenic differences of type 1 restriction-modification allele variants in experimental Listeria monocytogenes meningitis. Frontiers in Cellular and Infection Microbiology 2020 Oct 30; 10:590657. doi: 10.3389/fcimb.2020.590657
  4. Wysocka M, R Zamudio, MR Oggioni, J Gołębiewska, A Dudziak, B Krawczyk. The new Klebsiella pneumoniae ST152 variants with hypermucoviscous phenotype isolated from renal transplant recipients with asymptomatic bacteriuria – genetic characteristics by WGS. Genes. 2020 Oct 13;11(10):E1189. doi: 10.3390/genes11101189.
  5. Ricci S, D Grandgirard, I Masouris, T Braccini, G Pozzi, MR Oggioni, U Koedel, SL Leib. Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy. BMC Infectious Diseases 2020 Jul 13;20(1):505. doi: 10.1186/s12879-020-05226-w.
  6. Pan D, S Sze, JS Minhas, MN Bangash, N Pareek, P Divall, CML Williams, MR Oggioni, IB Squire, L Nellums, W Hanif, K Khunti, M Pareek. The impact of ethnicity on clinical outcomes in COVID-19: A rapid review. EClinicalMedicine 2020 June 3; 23:100404. doi: 10.1016/j.eclinm.2020.
  7. Zamudio R, RD Haigh, JD Ralph, M De Ste Croix, T Tasara, K Zurfluh, MJ Kwun, AD Millard, SD Bentley, NJ Croucher, R Stephan, MR Oggioni. 2020. Lineage specific evolution and gene flow in Listeria monocytogenes is independent of bacteriophages. Environmental Microbiology. 2020 June 1. doi 10.1111/1462-2920.15111.
  8. Monteiro T, M Wysocka, E Tellez, O Monteiro, L Spencer, E Veiga, S Monteiro, C de Pina, D Goncalves, S de Pina, L Correia, J Moreno, T Conceicao, M Aires De Sousa, H de Lencastre, LJ Gray, M Pareek, DR Jenkins, S Beleza, MR Oggioni, II Araujo, the ANCoVer project. 2020. A five-year retrospective study shows increasing rates of antimicrobial drug resistance in Cabo Verde for both Staphylococcus aureus and Escherichia coli. J. Global Antimicrob. Res. 2020 Apr 27; 22:483-487. doi: 10.1016/j.jgar.2020.04.002.
  9. Durmort C, G Ercoli, E Ramos-Sevillano, S Chimalapati, RD Haigh, M De Ste Croix, K Gould, J Hinds, Y Guerardel, T Vernet, MR Oggioni, JS Brown. Deletion of the zinc transporter lipoprotein AdcAII causes hyperencapsulation of Streptococcus pneumoniae associated with distinct alleles of the Type I restriction modification system. mBio 2020 Mar 31;11(2):e00445-20. doi: 10.1128/mBio.00445-20.
  10. De Ste Croix M, J Holmes, JJ Wanford, ER Moxon, MR Oggioni, CD Bayliss. 2020. Selective and non-selective bottlenecks as drivers of the evolution of hypermutable bacterial loci. Molecular Microbiology. 2020. 113(3):672-681. doi: 10.1111/mmi.14453
  11. Almebairik N, R Zamudio, C Joshi, C Ironside, JD Ralph, AP Roberts, IM Gould, JA Morrissey, K Hijazi, MR Oggioni. Genomic stability of composite SCCmec COMER-like and ACME genetic elements in Staphylococcus epidermidis correlates with rate of excision. Frontiers in Microbiology, 2020 Feb 12;11:166. doi: 10.3389/fmicb.2020.00166.
  12. De Ste Croix M, E Mitsi, A Morozov, S Glenn, PW Andrew, DM Ferreira and MR Oggioni. 2020. Phase variation in pneumococcal populations during carriage in the human nasopharynx. Scientific Reports. 2020 Feb 4;10(1):1803. doi: 10.1038/s41598-020-58684-2.
  13. Ramsheh MY, K Haldar, M Bafadhel, V Mistry, MR Oggioni, Brightling CE, MR Barer. Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes. Thorax. 2020 Jan;75(1):8-16. doi: 10.1136/thoraxjnl-2019-213485.
  14. Mitsi E, B Carniel, J Reiné, J Rylance, S Zaidi, A Soares-Schanoski, V Connor, AM Collins, A Schlitzer, E Nikolaou, C Solórzano, S Pojar, H Hill, AD Hyder-Wright, KC Jambo, MR Oggioni, M De Ste Croix,SB Gordon, SP Jochems, DM Ferreira. Nasal pneumococcal density is associated with microaspiration and heightened human alveolar macrophage responsiveness to bacterial pathogens. Am J Respir Crit Care Med. 2020 Feb 1;201(3):335-347. doi: 10.1164/rccm.201903-0607OC.
  15. Kwun MJ, MR Oggioni, SD Bentley, C Fraser, NJ Croucher. 2019. Synergistic activity of mobile genetic element defences in Streptococcus pneumoniae. Genes 2019 Sep 13;10(9). pii: E707. doi: 10.3390/genes10090707.
  16. Farzand R, K Rajakumar, R Zamudio, MR Oggioni, M Barer, H O'Hare. 2019. ICEKp2: description of an integrative and conjugative element in Klebsiella pneumoniae, co-occurring and interacting with ICEKp1". Scientific Reports. 2019 Sep 25;9(1):13892. doi: 10.1038/s41598-019-50456-x.
  17. Furi L, LA Crawford, G Rangel-Pineros, AS Manso, M De Ste Croix, RD Haigh, MJ Kwun, K Engelsen Fjelland, GD Gilfillan, SD Bentley, NJ Croucher, MR Clokie, MR Oggioni. Methylation warfare: interaction of pneumococcal bacteriophages with their host. Journal of Bacteriology. 2019 Sep 6;201(19). pii: e00370-19. doi: 10.1128/JB.00370-19.
  18. De Ste Croix M, Y Chen, I Vacca, A S Manso, C Johnston, P Polard, M J Kwun, S D Bentley, N J Croucher, C D Bayliss, R D Haigh, M R Oggioni. 2019. Recombination of the phase variable spnIII locus is independent of all known pneumococcal site-specific recombinases. Journal of Bacteriology. 2019 Jul 10;201(15). pii: e00233-19.Journal of Bacteriology. 2019 May 13. 201:e00233-19. https://doi.org/10.1128/JB.00233-19.
  19. Zamudio R, K Hijazi, C Joshi, E Aitken, MR Oggioni and Ian M Gould. 2019. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. Int. J. of Antimicrobial Agents. Jun;53(6):774-780. doi: 10.1016/j.ijantimicag.2019.02.022.
  20. Zamudio R., MR Oggioni, IM Gould, K Hijazi. 2019. Time for biocide stewardship? Nature Microbiology. 2019 May; 4(5):732-733. doi 10.1038/s41564-019-0360-6.
  21. Chung, W., Wanford, J., Kumar, R., Isherwood, J., Haigh, R., Oggioni, M., Dennison, A. and Ercoli, G. 2019. An ex vivo porcine spleen perfusion as a model of bacterial sepsis. Alternatives to animal experimentation. ALTEX. 2019;36(1):29-38. DOI: 10.14573/altex.1805131.
  22. George LM, Haigh RD, Mistry V, Haldar K, Barer MR, Oggioni MR, Brightling CE. 2018. Sputum Moraxella catarrhalis strains exhibit diversity within and between COPD subjects. Int J Chron Obstruct Pulmon Dis. 2018 Nov 8;13:3663-3667. doi: 10.2147/COPD.S180961
  23. Kwun MJ, MR Oggioni, M de Ste Croix, SD Bentley and NJ Croucher. 2018. Excision-reintegration at a pneumococcal phase-variable restriction-modification locus drives within- and between-strain epigenetic differentiation and inhibits gene acquisition. Nucleic Acids Research, 2018 1–16. doi: 10.1093/nar/gky906
  24. AL-Jabri Z, R Zamudio, E Horvath-Papp, JD.Ralph, Z AL-Muharrami, K Rajakumar and MR Oggioni. 2018. Integrase controlled excision of metal-resistance genomic islands in Acinetobacter baumannii. Genes (Basel). 2018 Jul 20;9(7). pii: E366. doi: 10.3390/genes9070366.
  25. Iannelli F, F Santoro, M Santagati, J-D Docquier, E Lazzeri, G Pastore, M Cassone, MR Oggioni, GM Rossolini, S Stefani, G Pozzi. 2018. Type M Resistance to Macrolides is Due to a Two-Gene Efflux Transport System of the ATP-Binding Cassette (ABC) Superfamily. Frontiers in Microbiology. 31 July 2018, 9:1670.doi 10.3389/fmicb.2018.01670.
  26. Ercoli G, VE Fernandes, WY Chung, JJ Wanford, S Thomson, CD Bayliss, K Straatman, PR Crocker, A Dennison, L Martinez-Pomares, PW Andrew, ER Moxon, MR Oggioni. 2018. Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia. Nature Microbiology. 3(5):600-610. doi 10.1038/s41564-018-0147-1
  27. Girt GC, A Mahindra, ZJH Al Jabri, M De Ste Croix, MR Oggioni and AG. Jamieson. 2018. Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus. Chemical Communications. 54(22):2767-2770. doi: 10.1039/c7cc06093a
  28. Haigh R, L Crawford, J Ralph, J Wanford, S Vartoukian, K Hijazi, W Wade, MR Oggioni. 2017. Draft whole genome sequences of the periodontal pathobionts Porphyromonas gingivalis, Prevotella intermedia and Tannerella forsythia contain phase variable restriction modification systems. Genome Announcements. 5(46). pii: e01229-17. doi: 10.1128/genomeA.01229-17.
  29. De Ste Croix M, I Vacca, M Jung Kwun, J Ralph, SD Bentley, R Haigh, NJ Croucher, MR Oggioni. 2017. Phase variable methylation and epigenetic control by Type I Restriction Modification systems. FEMS Microbiology Reviews. 41:S3-15. doi: 10.1093/femsre/fux025
  30. Kaduskar RD, G Della Scala, ZJH. Al Jabri, S Arioli, L Musso, MR Oggioni, S Dallavalle, D Mora. 2017. Promysalin is a salicylate containing antimicrobial with a cell membrane-disrupting mechanism of action on Gram-positive bacteria. ScientIfic Reports. 7: 8861. doi:10.1038/s41598-017-07567-0
  31. Trappetti C, LJ. McAllister, A Chen, H Wang, AW. Paton, MR. Oggioni, CA. McDevitt, JC. Paton. Autoinducer 2 signalling via the phosphotransferase FruA drives galactose utilization by Streptococcus pneumoniae resulting in hypervirulence. MBio. 2017 Jan 24;8(1). pii: e02269-16. doi: 10.1128/mBio.02269-16.
  32. Lees JA, PHC Kremer, AS Manso, NJ Croucher, B Ferwerda, M Valls Serón, MR Oggioni, J Parkhill, MC Brouwer, A van der Ende, D van de Beek, SD Bentley. 2017. Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis. Microbial Genomics, 2017. 3:1. doi: 10.1099/mgen.0.000103
  33. Hargreaves KR, Thanki AM, Jose BR, Oggioni MR, Clokie MR. 2016. Use of single molecule sequencing for comparative genomics of an environmental and a clinical isolate of Clostridium difficile ribotype 078. BMC Genomics. 2016 Dec 13;17(1):1020. PMID: 27964731. doi 10.1186/s12864-016-3346-2.
  34. Li P, C Tai, Z Deng, J Gan, MR Oggioni, H-Y Ou. 2016. Identification and characterization of chromosomal relBE toxin-antitoxin locus in Streptomyces cattleya DSM46488. Scientific reports. 6:32047. doi: 10.1038/srep32047.
  35. Furi L, R Haigh, ZJH Al Jabri, I Morrissey, H-Y Ou, R León-Sampedro, JL Martinez, TM Coque and MR Oggioni. 2016. Dissemination of novel antimicrobial resistance mechanisms through the insertion sequence mediated spread of metabolic genes. Front. Microbiol., 7,1008. doi: 10.3389/fmicb.2016.01008
  36. Curiao T, E Marchi, D Grandgirard, R León-Sampedro, C Viti, SL Leib, F Baquero, MR Oggioni, JL Martinez, TM Coque. 2016. Multiple adaptive routes of Salmonella enterica Typhimurium to biocide and antibiotic exposure. BMC Genomics. 2016 Jul 13;17:491. doi: 10.1186/s12864-016-2778-z.
  37. Hijazi K, I Mukhopadhya, F Abbott, K Milne, ZJ Al-Jabri, MR Oggioni, IM Gould. 2016. Susceptibility to chlorhexidine in multidrug resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections. International Journal of Antimicrobial Agents, pii: S0924-8579(16)30093-0. doi: 10.1016/j.ijantimicag.2016.04.015
  38. Velikova N, S Fulle, AS Manso, M Mechkarska, P Finn, JM Conlon, MR Oggioni, JM Wells, A Marina. 2016. Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens. Scientific Reports, 6:26085. doi: 10.1038/srep26085.
  39. Sánchez MB, F Decorosi, C Viti, MR. Oggioni, JL. Martinez, A Hernández. 2015. Predictive studies suggest that the risk for the selection of antibiotic resistance by biocides is likely low in Stenotrophomonas maltophilia. PLoS One. 10(7):e0132816. doi: 10.1371/journal.pone.0132816. eCollection 2015.
  40. Grandgirard D, L Furi, ML Ciusa, L Baldassarri, DR Knight, I Morrissey, CR Largiader, SL Leib, MR Oggioni. 2015. Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression. BMC Genomics 16(1):345. doi 10.1186/s12864-015-1544-y.
  41. Trappetti C and MR Oggioni. 2015. Biofilm formation under in vitro conditions. In: Streptococcus pneumoniae; Molecular mechanisms of host-pathogen interaction. Brown J., S. Hammerschmidt and C. Orihuela Eds., Academic Press, London. ISBN: 978-0-12-410530-0. p. 246-254.
  42. Curiao T, E Marchi, C Viti, MR Oggioni, F Baquero, J-L Martínez, T Coque. 2015. Polymorphic variation in sensitivity and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics. Antimicrobial Agents and Chemotherapy. 59(6):3413-23. doi: 10.1128/AAC.00187-15
  43. Oggioni MR, JR Coelho, L Furi, DR Knight, C Viti, G Orefici, J-L Martinez, AT Freitas, TM Coque, I Morrissey, on behalf of the Biohypo Consortium. 2015. Significant differences characterise the correlation coefficients between biocide and antibiotic susceptibility profiles in Staphylococcus aureus. Current Pharmaceutical Design, 21(16):2054-7. doi: 10.2174/1381612821666150310103238.
  44. Marchi E, Furi L, Arioli S, Morrissey I, Di Lorenzo V, Mora D, Giovannetti L, Oggioni MR, Viti C. 2015. Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus. Microbiological Research. 170:184-194. doi: 10.1016/j.micres.2014.07.001.
  45. Wright EA, V Di Lorenzo, C Trappetti, M Liciardi, G Orru, C Viti, C Bronowski, AJ Hall, AC Darby, MR Oggioni and C Winstanley, 2015. Divergence of a strain of Pseudomonas aeruginosa during an outbreak of ovine mastitis. Veterinary Microbiology, 175(1):105-13. doi: 10.1016/j.vetmic.2014.11.011
  46. Yavuz M, MR Oggioni, U Yetis and FB. Dilek. 2015. Biocides in drinking water system of Ankara, Turkey. Desalination and Water Treatment. 53:3253-3262. doi: 10.1080/19443994.2014.933626
  47. Ricci S, Grandgirard D, Wenzel M, Braccini T, Salvatore P, Oggioni MR, Leib SL, Koedel U. 2014. Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis. BMC Infect Dis., 14(1):3853. doi:10.1186/s12879-014-0726-6
  48. Iannelli F, M Santagati, F Santoro, MR Oggioni, S Stefani and G Pozzi. 2014. Nucleotide sequence of conjugative prophage phi1207.3 (formerly Tn1207.3) carrying the mef(A)/msr(D) genes for efflux resistance to macrolides in Streptococcus pyogenes. Frontiers in Microbiology 5:687. doi: 10.3389/fmicb.2014.00687
  49. Manso AS, MH Chai, JM Atack, L Furi, M De Ste Croix, R Haigh, C Trappetti, AD Ogunniyi, LK Shewell, M Boitano, TA Clark, J Korlach, M Blades, E Mirkes, AN Gorban, JC Paton, MP Jennings, MR Oggioni. 2014. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nature Commun. 5:5055 doi: 10.1038/ncomms6055
  50. Rukke HV, RS Kalluru, U Repnink, A Gerlini, RJ José, J Periselneris, H Marshall, G Griffiths, MR Oggioni, JS Brown, FC Petersen. 2014. Protective role of the capsule and impact of serotype 4 capsule switching on Streptococcus mitis. Infect Immun. 82(9):3790-801. doi: 10.1128/IAI.01840-14.
  51. Gerlini A, L Colomba, L Furi, T Braccini, AS Manso, A Pammolli, B Wang, A Vivi, M Tassini, N van Rooijen, G Pozzi, S Ricci, PW Andrew, U Koedel, ER Moxon and MR Oggioni. 2014. The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneck. PLoS Pathogens 10(3): e1004026. doi: 10.1371/journal.ppat.1004026.
  52. Morrissey I, MR Oggioni, D Knight, T Curiao,T Coque, A Kalkanci , JL Martinez and the BIOHYPO Consortium. 2014. Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS ONE, 9(1):e86669. doi:10.1371/journal.pone.0086669.
  53. Iannelli F, F Santoro, MR Oggioni, and G Pozzi. 2014. Nucleotide Sequence Analysis of Integrative Conjugative Element Tn5253 of Streptococcus pneumoniae. Antimicrob. Agents. Chemother. 58(2):1235-9. doi:10.1128/AAC.01764-13.
  54. Koc A, KB Orhon, A Ogutverici, L Furi, MR Oggioni, FB Dilek, and U Yetis. 2014. Is Adsorption an artefact in experimentation with triclosan? Desalination and Water Treatment, 52:7101-7107. doi:10.1080/19443994.2013.831780.
  55. Merker M, Kohl TA, Roetzer A, Truebe L, Richter E, Rüsch-Gerdes S, Fattorini L, Oggioni MR, Cox H, Varaine F, Niemann S. 2013. Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients. PLoS One. 2013;8(12):e82551. doi: 10.1371/journal.pone.0082551.
  56. Farhat MR, Shapiro BJ, Kieser KJ, Sultana R, Jacobson K, Victor TC, Warren RW, Streicher EM, Calver A, Sloutsky A, Kau D, Posey JE, Plikaytis B, Oggioni MR, Gardy JL, Johnston JC, Rodrigues M, Tang PKC, Kato-Maeda M, Kreiswirth B, Kurepina N, Borowski M, Muddukrishan B, Galagan J, Gagneux S, Birren B, Rubin EJ, Lander ES, Sabeti P, Murray M. 2013. Convergent Evolution Reveals Targets of Positive Selection in Drug Resistant Mycobacterium tuberculosis Strains. Nature Genetics. 45(10):1183-1189. doi: 10.1038/ng.2747.
  57. Ricci S, Gerlini A, Pammolli A, Chiavolini D, Braione V, Tripodi SA, Colombari B, Blasi E, Oggioni MR, Peppoloni S, Pozzi G. 2013 Contribution of different pneumococcal virulence factors to experimental meningitis in mice. BMC Infect Dis. 13(1):444. doi: 10.1186/1471-2334-13-444.
  58. Furi L, ML Ciusa, D Knight, V Di Lorenzo, N Tocci, D Cirasola, L Aragones, JR Coelho, AT Freitas, E Marchi, L Moce, P Visa, J Blackman Northwood, C Viti, E Borghi, G Orefici, the BIOHYPO consortium, I Morrissey, and MR Oggioni. 2013. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrob. Agents. Chemother. 57(8):3488-97. doi: 10.1128/AAC.00498-13.
  59. Maillard J-Y, S Bloomfield, JR Coelho, P Collier, B Cookson, S Fanning, A Hill, P Hartemann, A McBain, MR Oggioni, S Sattar, HP Schweizer, J Threlfall. 2013. Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment. Microb. Drug Res., 19(5):344-54 doi:10.1089/mdr.2013.0039.
  60. Oggioni MR, L. Furi, JR Coelho, JY Maillard, JL Martinez. 2013. Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics. Expert Review of Anti-infective Therapy. 11(4):363-6. doi: 10.1586/eri.13.16.
  61. Coelho JR, JA Carriço, D Knight, J-L Martínez, I Morrissey, MR Oggioni, and AT Freitas. 2013. The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus. PLoS One. 2013;8(2):e55582. doi: 10.1371/journal.pone.0055582.
  62. Tocci N, F Iannelli, A Bidossi, ML Ciusa, F Decorosi, C Viti, G Pozzi, S Ricci, MR Oggioni. 2013. Functional analysis of pneumococcal drug efflux pumps associates the MATE DinF transporter to quinolone susceptibility. Antimicrobial Agents Chemotherapy, 57(1):248–253. doi: 10.1128/AAC.01298-12.
  63. Kaur Hayre J, G Xu, L Borgianni, GL Taylor, PW Andrew, JD Docquier, MR Oggioni. 2012. Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases. BMC Biochemistry, 13(1):19. doi:10.1186/1471-2091-13-19.
  64. Oggioni MR, ML Ciusa, L Furi, L Baldassarri, G Orefici, D Cirasola, JL Martinez, I Morrissey, E Borghi. 2012. Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan. Antimicrobial Agents Chemotherapy, 56(11):6068-9. doi: 10.1128/AAC.01055-12
  65. Lazzeri E, F Santoro, M Oggioni, F Iannelli, and G Pozzi. 2012. Novel primers-probe sets for detection and identification of mycobacteria by PCR-microarray assay. Journal of Clinical Microbiology. 50(11):3777-9. doi: 10.1128/JCM.02300-12.
  66. Boianelli A, A Bidossi, L Gualdi, L Mulas, C Mocenni, G Pozzi, A Vicino, MR Oggioni. 2012. A non-linear deterministic model for regulation of diauxic lag on cellobiose by the pneumococcal multidomain transcriptional regulator CelR. PLoS ONE. 7(10): e47393. doi:10.1371/journal.pone.0047393.
  67. Gualdi L, J Kaur Hayre, A Gerlini, A Bidossi, L Colomba, C Trappetti, G Pozzi, JD Docquier, PW Andrew, S Ricci, and MR. Oggioni. 2012. Regulation of neuraminidase expression in Streptococcus pneumoniae. BMC Microbiology. 12(1):200. doi: 10.1186/1471-2180-12-200.
  68. Ciusa ML, Furi L, Knight D, Decorosi F, Fondi M, Raggi C, Coelho JR, Aragones L, Moce L, Visa P, Freitas AT, Baldassarri L, Fani R, Viti C, Orefici G, Martinez JL; the BIOHYPO Consortium, Morrissey I, Oggioni MR. 2012. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus. International Journal of Antimicrobial Agents. 40(3):210-220. doi: 10.1016/j.ijantimicag.2012.04.021
  69. Bidossi A., L. Mulas, F. Decorosi, L. Colomba, S. Ricci, G. Pozzi, J. Deutscher, C. Viti, MR Oggioni. 2012. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. PLoS ONE. 7(3):e33320. doi: 10.1371/journal.pone.0033320
  70. Ricci S, R Janulczyk, A Gerlini, V Braione, L Colomba, F Iannelli, D Chiavolini, MR Oggioni, L Björck, G Pozzi. 2011. The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis. Vaccine 29(46): 8241– 8249. doi: 10.1016/j.vaccine.2011.08.119
  71. Trappetti C, Potter AJ, Paton AW, Oggioni MR, Paton JC. 2011. LuxS Mediates iron-dependent biofilm formation, competence and fratricide in Streptococcus pneumoniae. Infection and Immunity. 79(11):4550-8. doi:10.1128/IAI.05644-11
  72. Kadioglu A, AM Cuppone, C Trappetti, T List, A Spreafico, G Pozzi, PW Andrew, MR Oggioni. 2011. Sex based differences in susceptibility to respiratory and systemic pneumococcal disease in mice. Journal of Infectious Disease, 204(12):1971-9. doi: 10.1093/infdis/jir657
  73. Bonnet M., M. Pardini, F. Meacci, G. Orru, H. Yesilkaya, T. Jarosz, PW Andrew, M Barer, F Checchi, H Rinder, G Orefici, S Rüsch-Gerdes, L Fattorini, MR Oggioni, J Melzer, S Niemann, F Varaine. 2011. Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection. PLoS ONE, 6(8):e23081. doi: 10.1371/journal.pone.0023081
  74. Trappetti C, AD Ogunniyi, MR Oggioni, and JC Paton. 2011. Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS ONE 6(5): e19844. doi:10.1371/journal.pone.0019844
  75. Trappetti C, L Gualdi, L Di Meola, P Jain, CC Korir, P Edmonds, F Iannelli, S. Ricci, G. Pozzi and MR. Oggioni. 2011. The impact of the competence quorum sensing system on Streptococcus pneumoniae biofilms varies depending on the experimental model. BMC Microbiology, 11(1):75. doi: 10.1186/1471-2180-11-75.
  76. Camilli R, R JP Bonnal, M Del Grosso, M Iacono, G Corti, E Rizzi, M Marchetti, L Mulas, F Iannelli, F Superti, MR Oggioni, G De Bellis and A Pantosti. 2011. Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate. BMC Microbiology, 11(1):25. doi: 10.1186/1471-2180-11-25.
  77. Xu G., M. Kiefel, J. Wilson, PW Andrew, MR Oggioni and G. Taylor. 2011. Three Streptococcus pneumoniae sialidases; three different products. Journal of the American Chemical Society. 133 (6):1718–1721. Doi: 10.1021/ja110733q
  78. Turroni F, F Bottacini, E Foroni, I Mulder, JH Kim, A Zomer, B Sánchez Garcia, A Bidossi, A Ferrarini, V Giubellini, M Delledonne, B Henrissat, P Coutinho, MR Oggioni, GF Fitzgerald, D Mills, A Margolles, D Kelly, D van Sinderen and M Ventura. 2010. Genome analysis of Bifidobacterium bifidum 317B reveals metabolic pathways for host-derived glycan foraging. Proceedings of the national Academy of Sciences PNAS. 107(45):19514-9. doi: 10.1073/pnas.1011100107
  79. Arioli S., E. Ragg, L. Scaglioni, D. Fessas, M Signorelli, M Karp, D Daffonchio, I De Noni, L Mulas, MR Oggioni, S Guglielmetti, and D Mora. 2010. Alkalizing reactions streamline cellular metabolism in acidogenic microorganisms. PLoS ONE 5(11):e15520. doi: 10.1371/journal.pone.0015520
  80. Donati C., N. L. Hiller, H. Tettelin, A. Muzzi, N. J. Croucher, S. V. Angiuoli, MR. Oggioni, J. C. Dunning Hotopp, F. Z. Hu, D. Riley, A. Covacci, T. J. Mitchell, S. D. Bentley, M. Kilian, G. D. Ehrlich, R. Rappuoli, E. R. Moxon and V. Masignani. 2010. Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biology, 11(10):R107. doi: 10.1186/gb-2010-11-10-r107
  81. Peppoloni S, Ricci S, Orsi CF, Colombari B, De Santi MM, Messinò M, Fabio G, Zanardi A, Righi E, Braione V, Tripodi S, Chiavolini D, Cintorino M, Zoli M, Oggioni MR, Blasi E, Pozzi G. 2010. The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia. Microbes and Infection. 12(12-13):990-1001. doi: 10.1016/j.micinf.2010.06.010
  82. Santoro F, MR. Oggioni, G Pozzi and F Iannelli. 2010. Nucleotide sequence and functional analysis of the tet(M)-carrying conjugative transposon Tn5251 of Streptococcus pneumoniae. FEMS Microbiology Lett. 308(2):150-158. DOI:10.1111/j.1574-6968.2010.02002.x
  83. Pianigiani, E. F. Ierardi, C. Cuciti, S. Brignali, MR. Oggioni, M. Fimiani. 2010. Processing efficacy in relation to microbial contamination of skin allografts from 723 donors. Burns 36(3):347-51. doi: 10.1016/j.burns.2009.04.020.
  84. Ventura M., F. Turroni, A. Zomer, E. Foroni, V. Giubellini, F. Bottacini, C. Canchaya, M.J. Claesson, F. He, M. Mantzourani, L. Mulas, A. Ferrarini, B. Gao, M. Delledonne, B. Henrissat, P. Coutinho, MR. Oggioni, R.S. Gupta, Z. Zhang, D. Beighton, G.F. Fitzgerald, P.W. O’Toole, and D. van Sinderen. 2009. The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genetics, 5(12):e1000785. doi: 10.1371/journal.pgen.1000785
  85. Pardini M, S Niemann, F Varaine, E Iona, F Meacci, G Orrù, H Yesilkaya, T Jarosz, PW Andrew, M Barer, F Checchi, H Rinder, G Orefici, S Rüesch-Gerdes, L Fattorini, MR Oggioni, M Bonnet. 2009. Characteristics of drug-resistant tuberculosis in Abkhazia, a high-prevalence area in Eastern Europe. Tuberculosis, 89:317–324. doi: 10.1016/j.tube.2009.04.002
  86. Serruto D., T Spadafina, M Scarselli, S Bambini, M Comanducci, S Höhle, M Kilian, E Veiga, P Cossart, MR. Oggioni, S Savino, I Ferlenghi, AR Taddei, R Rappuoli, M Pizza, V Masignani, and B Aricò. 2009. HadA is an atypical new multifunctional trimeric coiled-coil adhesin of Haemophilus influenzae biogroup aegyptius, which promotes entry into host cells. Cellular Microbiology. 11(7):1044-63. doi: 10.1111/j.1462-5822.2009.01306.x
  87. Smith CM, C LoPasso, A Scuderi, J Kolberg, H Baxendale, D Goldblatt, MR Oggioni, F Felici, PW Andrew. 2009. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae. European Journal of Immunology, 39(6):1527–1535. DOI 10.1002/eji.200839091
  88. Trappetti C, A Kadioglu, M Carter, J Athwal, F Iannelli, G Pozzi, PW Andrew, MR Oggioni. 2009. Sialic acid: a preventable signal for pneumococcal biofilm, colonisation and invasion of the host. The Journal of Infectious Disease. 199(10):1497-505. DOI: 10.1086/598483
  89. Xu G, JA Potter, RJ Russell, MR Oggioni, PW Andrew, G Taylor. 2008. Crystal structure of the NanB sialidase from Streptococcus pneumoniae. Journal of Molecular Biology. 384(2):436-49. doi: 10.1016/j.jmb.2008.09.032
  90. Luchini D, Meacci F, Oggioni MR, Morabito G, D'Amato V, Gabbrielli M, Pozzi G. 2008. Molecular detection of Leptospira interrogans in human tissues and environmental samples in a lethal case of leptospirosis. International Journal of Legal Medicine. 122(3):229-33. doi: 10.1007/s00414-007-0212-4
  91. De Paolis F, E Beghetto, A Spadoni, F Montagnani, F Felici, MR Oggioni, and N Gargano. 2007. Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae. BMC Microbiology, 7:113. doi: 10.1186/1471-2180-7-113. Doi: 10.1186/1471-2180-7-113
  92. Prete SP., A. Giuliani, S. D'Atri, G. Graziani, A. Balduzzi, MR. Oggioni, E. Iona, G. Girolomoni, L. Bonmassar, L. Romani, O. Francese. 2007. BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression. International Immunopharmacology 7(3):321–332. doi: 10.1016/j.intimp.2006.11.003
  93. Pardini M, F Varaine, M Bonnet, G Orefici, MR Oggioni, the LONG-DRUG Study Group and L Fattorini. 2007. Usefulness of the BACTEC MGIT 960 system for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. Journal of Clinical Microbiology, 45(2):575-576. doi: 10.1128/JCM.01985-06
  94. Oggioni MR, C Trappetti, A Kadioglu, M Cassone, F Iannelli, S Ricci, PW Andrew, G Pozzi. 2006. Switch from planktonic to sessile life; a major event in pneumococcal pathogenesis. Molecular Microbiology 61(5), 1196–1210. doi: 10.1111/j.1365-2958.2006.05310.x
  95. Kerr AR., GK Paterson, J. McCluskey, F. Iannelli, MR Oggioni, G Pozzi and Tim. J. Mitchell. 2006. PspC is a serotype specific pneumococcal virulence factor that interacts with nasopharyngeal complement in vivo. Infection and Immunity, 74(9):5319-5324. doi:10.1128/IAI.00543-06
  96. Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, Montagnani F, Oggioni MR, Pozzi G, and F Felici. 2006. Discovery of novel Streptococcus pneumoniae antigens by screening a whole genome lambda-display library. FEMS Microbiology Letters, 262(1):14-21. doi: 10.1111/j.1574-6968.2006.00360.x
  97. Yesilkaya H, F Meacci, S Niemann, D Hillemann S Rüsch-Gerdes, LONG DRUG study group, M.R. Barer, P.W. Andrew, and MR. Oggioni. 2006. Evaluation of Molecular Beacon, TaqMan, and FRET probes for the detection of antibiotic resistance conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts. Journal of Clinical Microbiology, 44(10):3826-3829. doi: 10.1128/JCM.00225-06
  98. Lazzi S, Bellan C, Tiacci E, Palummo N, Vatti R, Oggioni MR, Amato T, Schuerfeld K, Tonini T, Tosi P, Falini B, Leoncini L. 2006. IRTA1(+) monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgV(H) genes. The Journal of Pathology, 209(1):56-66. doi: 10.1002/path.1944
  99. Cassone M, MM D’Andrea., F Iannelli, MR. Oggioni, GM Rossolini, and G Pozzi. 2006. DNA microarrays for detection of macrolide resistance genes. Antimicrobial Agents and Chemotherapy, 50(6):2038-2041. doi: 10.1128/AAC.01574-05
  100. Romao S, G. Memmi, MR. Oggioni, MC. Trombe. 2006. LuxS impacts on LytA-dependent autolysis and on competence via metabolic and intercellular communication in Streptococcus pneumoniae. Microbiology,152(2):333-341. doi: 10.1099/mic.0.28406-0
  101. Camilli R., E. Pettini, M. Del Grosso, G. Pozzi, A. Pantosti, M.R. Oggioni. 2006 Zinc metalloproteinase genes in clinical isolates of Streptococcus pneumoniae: association of the full array with a clonal cluster comprising serotypes 8 and 11A. Microbiology, 152(2):313-321. doi: 10.1099/mic.0.28417-0
  102. Peppoloni S, B Colombari, R Neglia, D Quaglino, F Iannelli, MR Oggioni, G Pozzi, and E Blasi. 2006. The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Medical Microbiology and Immunology, 195(1):21-28. doi: 10.1007/s00430-005-0243-8
  103. Iannelli,F., MR Oggioni, G Pozzi. 2005. Sensor domain of histidine kinase ComD confers competence pherotype specificity in Streptoccoccus pneumoniae. FEMS Microbiology Letters, 252(2):321–326 doi: 10.1016/j.femsle.2005.09.008
  104. Meacci F, Orrù G, Iona E, Giannoni F, Piersimoni C, Pozzi G, Fattorini L, Oggioni MR. 2005. Drug Resistance Evolution of a Mycobacterium tuberculosis Strain from a Non-Compliant Patient. Journal of Clinical Microbiology, 43(7):3114–3120.
  105. Provvedi R., T. Maggi, MR Oggioni, R. Manganelli and G. Pozzi. 2005. Selection and characterization of a promoter for expression of single-copy recombinant genes in Gram-positive bacteria. BMC Biotechnology, 5(1):3. Doi: 10.1186/1472-6750-5-3
  106. Isola D, Pardini M, Varaine F, Niemann S, Rüsch-Gerdes S, L Fattorini, G Orefici, F Meacci, C Trappetti, MR Oggioni, the LONG-DRUG study group and G Orrù. 2005. A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. Journal of Microbiological Methods. 62(1):113-120.
  107. Pardini M, F. Varaine, E. Iona, E. Arzumanian, F. Checchi, MR. Oggioni, G. Orefici, and L. Fattorini. 2005. Cetyl-Pyridinium Chloride is useful for the isolation of Mycobacterium tuberculosis from long-term stored sputa. Journal of Clinical Microbiology, 43(1): 442–444.
  108. Oggioni MR., F. Iannelli, S. Ricci, D. Chiavolini, R. Parigi, C. Trappetti, J.-P. Claverys, and G. Pozzi. 2004. Antibacterial activity of a competence stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 48(12):4725–4732.
  109. Cairo F., Gaeta C., Dorigo W., Oggioni MR., Pratesi C., Pini Prato G.P., and G. Pozzi 2004. Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. Journal of Periodontal Research,39(6):442-446.
  110. Pozzi G, F. Iannelli, M.R. Oggioni, M. Santagati and S. Stefani. 2004. Genetic Elements Carrying Macrolide Efflux Genes in Streptococci. Current Drug Targets. Infectious Disorders, 4(3):203-6.
  111. Chiavolini D., S. Tripodi, R. Parigi, MR Oggioni, E. Blasi, M. Cintorino, G. Pozzi, and S. Ricci 2004. Method for inducing experimental pneumococcal meningitis in outbred mice. BMC Biotechnology, 4:36. Doi: 10.1186/1471-2180-4-36.
  112. CiabattiniA, R. Parigi, R Istigato, MR Oggioni, and G Pozzi. 2004. Oral priming of mice using recombinant spores of Bacillus subtilis. Vaccine, 22(31-32):4139-4143.
  113. Marcotte H, Ferrari S, Cesena C, Hammarström L, Morelli L, Pozzi G and MR Oggioni. 2004. The aggregation promoting factor of Lactobacillus crispatus M247 and its genetic locus. Journal of Applied Microbiology, 97(4):749-756.
  114. Iannelli F., D.Chiavolini, S. Ricci, M.R. Oggioni, and Gianni Pozzi. 2004. Pneumococcal surface protein C (PspC) contributes to sepsis caused by Streptococcus pneumoniae in mice. Infection and Immunity, 72(5): 3077-3080.
  115. Santagati M., F. Iannelli, C. Cascone, F. Campanile, M.R. Oggioni, S. Stefani, and G. Pozzi. 2003. The novel conjugative transposon Tn1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microbial Drug Resistance, 9(3):243-247.
  116. Chiavolini D., G. Memmi, T. Maggi, F. Iannelli, G. Pozzi and M.R. Oggioni. 2003. The three extra-cellular zinc metalloproteinases of Streptococcus pneumoniae have a different impact on virulence in mice. BMC Microbiology, 3:14. doi: 10.1186/1471-2180-3-14
  117. Oggioni M.R., G. Memmi, T. Maggi, D. Chiavolini, F. Iannelli and G. Pozzi. 2003. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Molecular Microbiology 49(3):795-805.
  118. Oggioni M.R., A. Ciabattini, A.M.Cuppone, G. Pozzi. 2003. Bacillus spores for vaccine delivery. Vaccine, 21(S2):S96-S101.
  119. Oggioni M.R., F. Meacci, A. Carattoli, A. Ciervo, G. Orrù, A. Cassone and G. Pozzi. 2002. Protocol for real-time PCR identification of anthrax spores from nasal swabs after broth enrichment. Journal of Clinical Microbiology, 40(11): 3956-3963.
  120. Magliani W, S. Conti, R. Frazzi, G. Pozzi, M.R. Oggioni, L. Polonelli. 2002. Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants. Biotechnology & Genetic Engineering Reviews, 19:139-56.
  121. Maggi T., M.R. Spinosa, S. Ricci, D. Medaglini, G. Pozzi, and M.R. Oggioni. 2002. Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface. FEMS Microbiology Letters, 210(1):135-41. Doi: 10.1111/j.1574-6968.2002.tb11172.x
  122. Biondo C., C. Beninati, D. Delfino, M.R. Oggioni, G. Mancuso, Midiri A., Bombaci M., Tomaselli G., and G. Teti. 2002. Identification and cloning of a cryptococcal deacetylase that produces protective immune responses. Infection and Immunity, 70(5):2383-2391.
  123. Iannelli F., M.R. Oggioni, and G. Pozzi. 2002. Allelic variation in the highly polymorphic locus pspc of Streptococcus pneumoniae. Gene, 284(1-2):63-71.
  124. Isticato R, G. Cangiano, H.T. Tran, A. Ciabattini, D. Medaglini, M.R. Oggioni, M. De Felice, G. Pozzi, E. Ricca, 2001. Surface display of recombinant proteins on Bacillus subtilis spores. Journal of Bacteriology, 183(21):6294-6301.
  125. Oggioni M.R. and G. Pozzi. 2001. Comparative genomics for identification clone-specific sequence blocks in Streptococcus pneumoniae. FEMS Microbiology Letters, 200:137-143. Doi: 10.1111/j.1574-6968.2001.tb10705.x
  126. Beninati C., Oggioni M.R., Mancuso G., Midiri A., Polonelli L., Pozzi G., Teti G. 2001. Anti-idiotypic vaccination against group B streptococci. International Reviews of Immunology, 20(2):263-273.
  127. Oggioni M.R., Beninati C, M.Boccanera, D. Medaglini, M.R.Spinosa T.Maggi S. Conti, W. Magliani, F. De Bernardis, G. Teti, A. Cassone, G. Pozzi, and L. Polonelli. 2001. Recombinant Streptococcus gordonii for Mucosal Delivery of a scFv Microbicidal Antibody. International Reviews of Immunology.20(2): 275-287.
  128. Medaglini D., A. Ciabattini, M.R. Spinosa, T. Maggi, H. Marcotte, M.R. Oggioni and G. Pozzi. 2001. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine, 19(15-16):1931-1939.
  129. Santagati M., F. Iannelli, M.R. Oggioni, S. Stefani, and G. Pozzi. 2000. Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 44(9):2585-2587.
  130. Talay S.R., A. Zock, M. Rohde, G. Molinari, M.R. Oggioni, G. Pozzi, C.A. Guzman, and G.S. Chhatwal. 2000. Cooperative binding of human fibronectin to SfbI protein triggers streptococcal invasion into respiratory epithelial cells. Cellular Microbiology, 2(6):521-536.
  131. Beninati C, M.R.Oggioni M.Boccanera M.R.Spinosa T.Maggi S. Conti, W. Magliani, F. De Bernardis, G. Teti, A. Cassone, G. Pozzi, and L. Polonelli. 2000. Therapy of experimental mucosal candidiasis by a microbicidal anti-idiotypic antibody locally delivered by an engineered human commensal bacterium. Nature Biotechnology, 18(10):1060-1064. doi:10.1038/80250
  132. Spinosa, M.R., F. Wallet, R.J. Courcol and M.R. Oggioni. 2000. The trouble in tracing opportunistic pathogens: cholangitis due to Bacillus in a French Hospital caused by a strain related to an Italian probiotic? Microbial Ecology in Health and Disease,12(2):99-101. doi:10.1080/089106000435491
  133. Spinosa, M.R., T. Braccini, E. Ricca, M. De Felice, L. Morelli, G. Pozzi and M.R. Oggioni. 2000. On the fate of ingested Bacillus spores. Research in Microbiology, 151(5): 361-368. Doi: 10.1016/S0923-2508(00)00159-5
  134. Maggi T., M.R. Oggioni, D. Medaglini, M.L. Bianchi Bandinelli, D. Soldateschi, K.H. Wiesmüller, C.P. Muller, P.E. Valensin and G. Pozzi. 2000. Expression of Measles Virus Antigens in Streptococcus gordonii. New Microbiologica 23(4): 119-128.
  135. Fattorini L., E. Iona, M.L., Ricci O.F Thoesen., G. Orrù, M.R. Oggioni., E. Tortoli, C. Piersimoni, P. Chiaradonna, M. Tronci, G. Pozzi, and G. Orefici. 1999. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microbial Drug Resistance, 5(4):265-270.
  136. Oggioni, M.R. and J.-P. Claverys. 1999 Repeated extragenic sequences in procaryotic genomes: a proposal for the origin and dynamics of the RUP element in Streptococcus pneumoniae. Microbiology 145:2647-2653.
  137. Oggioni, M.R., D. Medaglini, T. Maggi and G. Pozzi. 1999. Engineering the Gram-positive cell surface for the construction of bacterial vaccine vectors. Methods 19(1):163-173.
  138. Oggioni, M.R., D. Medaglini, L. Romano, F. Peruzzi, T. Maggi, L. Lozzi, L. Bracci, M. Zazzi, F. Manca, P.E. Valensin and G. Pozzi. 1999. Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Research and Human Retroviruses 15(5):451-459.
  139. Pozzi, G., M. Meloni, E. Iona, G. Orrù O.F. Thorensen, M.L. Ricci, M.R. Oggioni, L. Fattorini and G. Orefici. 1999. rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. Journal of Clinical Microbiology, 37:1197-1199.
  140. Oggioni M.R., F. Iannelli and G. Pozzi. 1999. Characterization of cryptic plasmids pDP1 and pSMB1 of Streptococcus pneumoniae. Plasmid, 41:70-72.
  141. Medaglini D., T. Maggi, S. Ricci, M.R. Oggioni, and G. Pozzi. 1998. Recombinant Streptococcus gordonii as a mucosal vaccine vector. Periodicum Biologorum, ISSN: 0031-5362 100(4):455-458.
  142. Medaglini D., T. Maggi, P. Sestini, S. Di Fabio, M. Pace, F. Titti, M.R. Oggioni, and G. Pozzi. 1998. Mucosal vaccine delivery in the female genital tract by recombinant Gram-positive bacteria. Periodicum Biologorum, ISSN: 0031-5362 100(4):435-440.
  143. Manganelli R., R. Provvedi, C. Berneri, M.R. Oggioni and G. Pozzi. 1998. Insertion vectors for construction of recombinant conjugative transposons in Bacillus subtilis and Enterococcus faecalis. FEMS Microbiology Letters,168 :259-268. Doi:10.1111/j.1574-6968.1998.tb13282.x
  144. Oggioni MR, Pozzi G, Valensin PE, Galieni P, Bigazzi C. 1998. Recurrent septicaemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. Journal of Clinical Microbiology, 36:325-326.
  145. Medaglini D., M.R. Oggioni and G. Pozzi. 1998. Vaginal immunization with recombinant Gram-positive bacteria. American Journal of Reproductive Immunology, 39: 199-208.
  146. Medaglini, D., S. Ricci, T. Maggi, C.M. Rush, R. Manganelli, M.R. Oggioni and G. Pozzi. 1997. Recombinant Gram-positive bacteria as vehicles of vaccine antigens. Biotechnology Annual Review, 3:297-312.
  147. Oggioni, M.R., C.G. Dowson, J. Maynard Smith, R. Provvedi and G. Pozzi. 1996. The tetracycline resistance gene tet(M) exhibits mosaic structure. Plasmid, 35:156-163.
  148. Oggioni, M.R. and G. Pozzi. 1996. A host-vector system for heterologous gene expression in Streptococcus gordonii. Gene, 169:85-90.
  149. Oggioni, M.R., L. Fattorini, B. Li, A. De Milito, M. Zazzi, G. Pozzi, G. Orefici, and P.E. Valensin. 1995. Identification of Mycobacterium tuberculosis complex, Mycobacterium avium, and Mycobacterium intracellulare by selective nested polymerase chain reaction. Molecular and Cellular Probes, 9:321-326.
  150. Oggioni M.R., R. Manganelli, M. Contorni, M. Tommasino, and G. Pozzi. 1995. Immunization of mice by oral colonization with live recombinant commensal streptococci. Vaccine, 13:775-779.
  151. Pozzi, G., M.R. Oggioni, R. Manganelli, D. Medaglini, V.A. Fischetti, D. Fenoglio, M.T. Valle, A. Kunkl and F. Manca. 1994. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.. Vaccine, 12:1071-1077.
  152. Fischetti, V.A., D. Medaglini, M.R. Oggioni, and G. Pozzi. 1993. Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery. Current Opinion in Biotechnology, 4:603-610.
  153. Pozzi, G., M.R. Oggioni, R. Manganelli, and V.A. Fischetti. 1992. Expression of the M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Research in Microbiology, 143:449-457.
  154. Pozzi, G., M. Contorni, M.R. Oggioni, R. Manganelli, M. Tommasino, F. Cavalieri, and V.A. Fischetti. 1992. Delivery and expression of a heterologous antigen on the surface of streptococci. Infection and Immunity, 60:1902-1907.
  155. Oggioni, M.R., R. Manganelli, P. Plevani, V.A. Fischetti, and G. Pozzi. 1992. Expression of M6 protein of Streptococcus pyogenes on the surface of Streptococcus gordonii Challis. Zentralblatt für Bakteriologie, Suppl. 22:350-352.
  156. Manganelli, R., M.R. Oggioni, and G. Pozzi. 1992. A Tn916-like element integrated into the conjugative transposon Tn5253. Zentralblatt für Bakteriologie, Suppl. 22:390-391.
  157. Oggioni, M.R., and G. Pozzi. 1990. Conjugative mobilisation of the cloned M6 protein gene from Streptococcus pneumoniae to Streptococcus pyogenes. Microbiologica, 13:273-281.
  158. Pozzi, G., R.A. Musmanno, P.M.-J. Lievens, M.R. Oggioni, P. Plevani, and R. Manganelli. 1990. Method and parameters for genetic transformation of Streptococcus sanguis Challis. Research in Microbiology, 141:659-670.
  159. Pozzi, G., M.R. Oggioni, and A. Tomasz. 1989. DNA probe for identification of Streptococcus pneumoniae. Journal of Clinical Microbiology, 27:370-372.
  160. Pozzi, G., R.A. Musmanno, E.A. Renzoni, M.R. Oggioni, and M.G. Cusi. 1988. Host vector system for integration of recombinant DNA into chromosomes of transformable and non transformable streptococci. Journal of Bacteriology, 170:1969-1972.

Latest news

At the moment no news are available.

RSS